Duhaylungsod, Charlene T.

HRN: 20-15-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CEFUROXIME 750MG (VIAL)
04/30/2022
05/01/2022
IVT
750mg
Q8H
S/P 1° CS Due To Breech

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominalReproductive Tract    Compliance to guidelines: Guideline Not Available